For three years, staffers at UCLA Health have been quietly fulfilling final wishes for dying patients in the intensive care unit. Amid the isolating forces of the pandemic, their work has become all the more meaningful.
Amid questions about the accuracy of the COVID-19 antibody tests flooding the market — and the usefulness of the results they provide — the FDA has belatedly stepped in to try to rein in the chaos.
The pandemic has forced millions of families to weigh the risks of vulnerable grandparents getting too close to their beloved grandchildren — against the heartache of staying away.
A possibility that the blood of people who had COVID could save others has set off a mad scramble for donors — with top-dollar offers and a plan that relies on the blood of 10,000 Orthodox Jewish women.
Public officials are putting high hopes on new blood tests as a means of determining who has developed antibodies to COVID-19, and with those antibodies, presumed immunity. But experts caution the tests are largely unreliable and the science is still catching up.
COVID-19 is changing medical care, not only for vulnerable elders but also for pregnant women and their babies entering the world.
En todo los Estados Unidos, COVID-19 está alterando radicalmente la atención médica, no solo para los adultos mayores vulnerables sino también para las embarazadas y sus recién nacidos.
As efforts ramp up to collect blood plasma from the first survivors of COVID-19, families of critically ill patients are jockeying to obtain the still-unproven antibody treatment.
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
New guidelines issued Tuesday could speed a century-old therapy to those critically ill with the pandemic virus.